| Erik H Groscost, CRNA | |
|
990 Oak Ridge Tpke, Oak Ridge, TN 37830-6976 | |
| (865) 481-1112 | |
| (770) 237-1124 |
| Full Name | Erik H Groscost |
|---|---|
| Gender | Male |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 26 Years |
| Location | 990 Oak Ridge Tpke, Oak Ridge, Tennessee |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1639148505 | NPI | - | NPPES |
| 145957 | Other | TN | NURSING LICENSE # |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | 145957 (Tennessee) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Blount Memorial Hospital | Maryville, TN | Hospital |
| University Of Tn Medical Center | Knoxville, TN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Blount Memorial Physician Group Inc | 6406844174 | 242 |
| Mmc Anesthesia Group, Pc | 6901795830 | 138 |
| University Anesthesiologists, Pllc | 8921097197 | 153 |
News Archive
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, and collaborators from the David H. Koch Institute for Integrative Research at the Massachusetts Institute of Technology (MIT) today announced the publication of new data in the journal Proceedings of the National Academy of Sciences (PNAS) describing further advancements in discovery and development of novel "lipidoid" formulations for the systemic delivery of RNAi therapeutics.
More than 20 million Americans have gained health insurance coverage through the Affordable Care Act and do not have to pay for 15 preventive screenings recommended by the U.S. Preventive Services Task Force.
Hard to Treat Diseases announces that Collagenna Skin care Products has entered into an exclusive distribution agreement with Alphaderm Body and Wellness for Switzerland.
Measuring a woman's bone mineral density can provide additional information that may help more accurately determine a woman's risk of developing breast cancer. That is the conclusion of a new study published in the September 1, 2008 issue of CANCER, a peer-reviewed journal of the American Cancer Society.
› Verified 8 days ago
| Entity Name | Mmc Anesthesia Group, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1639148117 PECOS PAC ID: 6901795830 Enrollment ID: O20040310001466 |
News Archive
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, and collaborators from the David H. Koch Institute for Integrative Research at the Massachusetts Institute of Technology (MIT) today announced the publication of new data in the journal Proceedings of the National Academy of Sciences (PNAS) describing further advancements in discovery and development of novel "lipidoid" formulations for the systemic delivery of RNAi therapeutics.
More than 20 million Americans have gained health insurance coverage through the Affordable Care Act and do not have to pay for 15 preventive screenings recommended by the U.S. Preventive Services Task Force.
Hard to Treat Diseases announces that Collagenna Skin care Products has entered into an exclusive distribution agreement with Alphaderm Body and Wellness for Switzerland.
Measuring a woman's bone mineral density can provide additional information that may help more accurately determine a woman's risk of developing breast cancer. That is the conclusion of a new study published in the September 1, 2008 issue of CANCER, a peer-reviewed journal of the American Cancer Society.
› Verified 8 days ago
| Entity Name | Blount Memorial Physician Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1699710194 PECOS PAC ID: 6406844174 Enrollment ID: O20040503000547 |
News Archive
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, and collaborators from the David H. Koch Institute for Integrative Research at the Massachusetts Institute of Technology (MIT) today announced the publication of new data in the journal Proceedings of the National Academy of Sciences (PNAS) describing further advancements in discovery and development of novel "lipidoid" formulations for the systemic delivery of RNAi therapeutics.
More than 20 million Americans have gained health insurance coverage through the Affordable Care Act and do not have to pay for 15 preventive screenings recommended by the U.S. Preventive Services Task Force.
Hard to Treat Diseases announces that Collagenna Skin care Products has entered into an exclusive distribution agreement with Alphaderm Body and Wellness for Switzerland.
Measuring a woman's bone mineral density can provide additional information that may help more accurately determine a woman's risk of developing breast cancer. That is the conclusion of a new study published in the September 1, 2008 issue of CANCER, a peer-reviewed journal of the American Cancer Society.
› Verified 8 days ago
| Entity Name | University Anesthesiologists, Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073619466 PECOS PAC ID: 8921097197 Enrollment ID: O20040511001722 |
News Archive
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, and collaborators from the David H. Koch Institute for Integrative Research at the Massachusetts Institute of Technology (MIT) today announced the publication of new data in the journal Proceedings of the National Academy of Sciences (PNAS) describing further advancements in discovery and development of novel "lipidoid" formulations for the systemic delivery of RNAi therapeutics.
More than 20 million Americans have gained health insurance coverage through the Affordable Care Act and do not have to pay for 15 preventive screenings recommended by the U.S. Preventive Services Task Force.
Hard to Treat Diseases announces that Collagenna Skin care Products has entered into an exclusive distribution agreement with Alphaderm Body and Wellness for Switzerland.
Measuring a woman's bone mineral density can provide additional information that may help more accurately determine a woman's risk of developing breast cancer. That is the conclusion of a new study published in the September 1, 2008 issue of CANCER, a peer-reviewed journal of the American Cancer Society.
› Verified 8 days ago
| Entity Name | American Anesthesiology Of Tennessee Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1609822998 PECOS PAC ID: 9931001922 Enrollment ID: O20040713001364 |
News Archive
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, and collaborators from the David H. Koch Institute for Integrative Research at the Massachusetts Institute of Technology (MIT) today announced the publication of new data in the journal Proceedings of the National Academy of Sciences (PNAS) describing further advancements in discovery and development of novel "lipidoid" formulations for the systemic delivery of RNAi therapeutics.
More than 20 million Americans have gained health insurance coverage through the Affordable Care Act and do not have to pay for 15 preventive screenings recommended by the U.S. Preventive Services Task Force.
Hard to Treat Diseases announces that Collagenna Skin care Products has entered into an exclusive distribution agreement with Alphaderm Body and Wellness for Switzerland.
Measuring a woman's bone mineral density can provide additional information that may help more accurately determine a woman's risk of developing breast cancer. That is the conclusion of a new study published in the September 1, 2008 issue of CANCER, a peer-reviewed journal of the American Cancer Society.
› Verified 8 days ago
| Entity Name | Lifelinc Anesthesia Ii, Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1821397233 PECOS PAC ID: 2668658493 Enrollment ID: O20110512000311 |
News Archive
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, and collaborators from the David H. Koch Institute for Integrative Research at the Massachusetts Institute of Technology (MIT) today announced the publication of new data in the journal Proceedings of the National Academy of Sciences (PNAS) describing further advancements in discovery and development of novel "lipidoid" formulations for the systemic delivery of RNAi therapeutics.
More than 20 million Americans have gained health insurance coverage through the Affordable Care Act and do not have to pay for 15 preventive screenings recommended by the U.S. Preventive Services Task Force.
Hard to Treat Diseases announces that Collagenna Skin care Products has entered into an exclusive distribution agreement with Alphaderm Body and Wellness for Switzerland.
Measuring a woman's bone mineral density can provide additional information that may help more accurately determine a woman's risk of developing breast cancer. That is the conclusion of a new study published in the September 1, 2008 issue of CANCER, a peer-reviewed journal of the American Cancer Society.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Erik H Groscost, CRNA Po Box 5059, Oak Ridge, TN 37831-5059 Ph: (800) 611-6713 | Erik H Groscost, CRNA 990 Oak Ridge Tpke, Oak Ridge, TN 37830-6976 Ph: (865) 481-1112 |
News Archive
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, and collaborators from the David H. Koch Institute for Integrative Research at the Massachusetts Institute of Technology (MIT) today announced the publication of new data in the journal Proceedings of the National Academy of Sciences (PNAS) describing further advancements in discovery and development of novel "lipidoid" formulations for the systemic delivery of RNAi therapeutics.
More than 20 million Americans have gained health insurance coverage through the Affordable Care Act and do not have to pay for 15 preventive screenings recommended by the U.S. Preventive Services Task Force.
Hard to Treat Diseases announces that Collagenna Skin care Products has entered into an exclusive distribution agreement with Alphaderm Body and Wellness for Switzerland.
Measuring a woman's bone mineral density can provide additional information that may help more accurately determine a woman's risk of developing breast cancer. That is the conclusion of a new study published in the September 1, 2008 issue of CANCER, a peer-reviewed journal of the American Cancer Society.
› Verified 8 days ago
Harber Ingle, CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 990 Oak Ridge Tpke, Oak Ridge, TN 37830 Phone: 800-611-6713 | |
Kenneth L Boswell, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 990 Oak Ridge Tpke, Oak Ridge, TN 37830 Phone: 865-481-1112 Fax: 770-237-1124 | |
Lacey King, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 990 Oak Ridge Tpke, Oak Ridge, TN 37830 Phone: 865-835-3560 | |
Doris Lewis, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 990 Oak Ridge Tpke, Anesthesia Dept, Oak Ridge, TN 37830 Phone: 865-481-1112 Fax: 770-237-1124 | |
Micah Shea Clark, Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 990 Oak Ridge Tpke, Oak Ridge, TN 37830 Phone: 931-858-6303 Fax: 931-858-6305 | |
Roger B Lee, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 990 Oak Ridge Tpke, Anesthesia Dept, Oak Ridge, TN 37830 Phone: 800-611-6713 Fax: 770-237-1124 | |
Christina Bonner, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 990 Oak Ridge Tpke, Oak Ridge, TN 37830 Phone: 865-481-1112 Fax: 770-237-1124 |